Literature DB >> 17641836

Expression and functional role of HERG1, K+ channels in leukemic cells and leukemic stem cells.

Huiyu Li1, Liqiong Liu, Tiannan Guo, Jiahua Zhang, Xiaoqing Li, Wen Du, Wei Liu, Xiangjun Chen, Shi'ang Huang.   

Abstract

In order to investigate the expression and functional role of HERG1 K+ channels in leukemic cells and leukemic stem cells (LSCs), RT-PCR was used to detect the HERG1 K+ channels expression in leukemic cells and LSCs. The functional role of HERG1 K+ channels in leukemic cell proliferation was measured by MTT assay, and cell cycle and apoptosis were analyzed by flow cytometry. The results showed that herg mRNA was expressed in CD34+/CD38-, CD123+ LSCs but not in circulating CD34+ cells. Herg mRNA was also up-regulated in leukemia cell lines K562 and HL60 as well as almost all the primary leukemic cells while not in normal peripheral blood mononuclear cells (PBMNCs) and the expression of herg mRNA was not associated with the clinical and cytogenetic features of leukemia. In addition, leukemic cell proliferation was dramatically inhibited by HERG K+ channel special inhibitor E-4031. Moreover, E-4031 suppressed the cell growth by inducing a specific block at the G1/S transition phase of the cell cycle but had no effect on apoptosis in leukemic cells. The results suggested that HERG1 K+ channels could regulate leukemic cells proliferation and were necessary for leukemic cells to proceed with the cell cycle. HERG1 K+ channels may also have oncogenic potential and may be a biomarker for diagnosis of leukemia and a novel potential pharmacological target for leukemia therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641836     DOI: 10.1007/s11596-007-0310-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  16 in total

1.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Authors:  C T Jordan; D Upchurch; S J Szilvassy; M L Guzman; D S Howard; A L Pettigrew; T Meyerrose; R Rossi; B Grimes; D A Rizzieri; S M Luger; G L Phillips
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

2.  Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells.

Authors:  Olivia Crociani; Leonardo Guasti; Manuela Balzi; Andrea Becchetti; Enzo Wanke; Massimo Olivotto; Randy S Wymore; Annarosa Arcangeli
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

3.  Identification of two nervous system-specific members of the erg potassium channel gene family.

Authors:  W Shi; R S Wymore; H S Wang; Z Pan; I S Cohen; D McKinnon; J E Dixon
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

4.  Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells.

Authors:  Garth A M Smith; Hing-Wo Tsui; Evan W Newell; Xinpo Jiang; Xiao-Ping Zhu; Florence W L Tsui; Lyanne C Schlichter
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

5.  HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors.

Authors:  S Pillozzi; M F Brizzi; M Balzi; O Crociani; A Cherubini; L Guasti; B Bartolozzi; A Becchetti; E Wanke; P A Bernabei; M Olivotto; L Pegoraro; A Arcangeli
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

6.  Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.

Authors:  A Blair; D E Hogge; H J Sutherland
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

7.  herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells.

Authors:  Elena Lastraioli; Leonardo Guasti; Olivia Crociani; Simone Polvani; Giovanna Hofmann; Harry Witchel; Lapo Bencini; Massimo Calistri; Luca Messerini; Marco Scatizzi; Renato Moretti; Enzo Wanke; Massimo Olivotto; Gabriele Mugnai; Annarosa Arcangeli
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

8.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

Authors:  M E Curran; I Splawski; K W Timothy; G M Vincent; E D Green; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium.

Authors:  A Cherubini; G L Taddei; O Crociani; M Paglierani; A M Buccoliero; L Fontana; I Noci; P Borri; E Borrani; M Giachi; A Becchetti; B Rosati; E Wanke; M Olivotto; A Arcangeli
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines.

Authors:  A Masi; A Becchetti; R Restano-Cassulini; S Polvani; G Hofmann; A M Buccoliero; M Paglierani; B Pollo; G L Taddei; P Gallina; N Di Lorenzo; S Franceschetti; E Wanke; A Arcangeli
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

View more
  4 in total

1.  Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.

Authors:  Kelli B Pointer; Paul A Clark; Kevin W Eliceiri; M Shahriar Salamat; Gail A Robertson; John S Kuo
Journal:  Clin Cancer Res       Date:  2016-09-15       Impact factor: 12.531

2.  Prognostic significance of hERG1 expression in gastric cancer.

Authors:  Xiang-Wu Ding; Wen-Bin Yang; Shan Gao; Wei Wang; Zheng Li; Wang-Ming Hu; Jian-Jun Li; He-Sheng Luo
Journal:  Dig Dis Sci       Date:  2009-06-03       Impact factor: 3.199

3.  MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.

Authors:  Abdullah A Assiri; Noha Mourad; Minghai Shao; Patrick Kiel; Wanqing Liu; Todd C Skaar; Brian R Overholser
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 4.  Novel roles for hERG K(+) channels in cell proliferation and apoptosis.

Authors:  J Jehle; P A Schweizer; H A Katus; D Thomas
Journal:  Cell Death Dis       Date:  2011-08-18       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.